Dental Care Clinics in Russellville, AL Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Rousseau Dental Care Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 510 Engle Dr Se, Russellville, AL 35653 Phone: 256-332-6073 Fax: 256-332-6655 |
Mark E. Love Dmd ,pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 510 Engle Dr Se, Russellville, AL 35653 Phone: 256-332-6073 Fax: 256-332-6655 |
Russellville Dental Care, P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 510 Engle Dr Se, Russellville, AL 35653 Phone: 256-332-6073 Fax: 256-332-6655 |
Russellville Family Dentistry Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 510 Engle Dr Se, Russellville, AL 35653 Phone: 256-332-6073 Fax: 256-332-6655 |
Steven D. Hammack D.m.d. Dentist Medicare: Not Enrolled in Medicare Practice Location: 531 Saint Clair St Se, Russellville, AL 35653 Phone: 256-332-6888 Fax: 256-332-9951 |
Srd Russellville Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 531 Saint Clair St Se, Russellville, AL 35653 Phone: 256-332-6888 |
News Archive
China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009").
Alcohol and drugs put teens at increased risk for unsafe driving
Teenagers who drink alcohol and smoke marijuana may be at increased risk for unsafe driving, according to a study in the May issue of the Journal of Studies on Alcohol and Drugs.
Researchers identify part of the brain that responds to both facial and vocal expressions of emotion
Researchers at the University of York have identified a part of the brain that responds to both facial and vocal expressions of emotion.
CytRx to present bafetinib preclinical study results at AACR Annual Meeting
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies demonstrating that its oncology drug candidate bafetinib inhibits bone destruction in model systems is being presented on April 2, 2011 at the American Academy for Cancer Research 102nd Annual Meeting in Orlando, Florida.
› Verified 7 days ago